ArticleSignal transduction and targeted therapy2022

Artesunate suppresses Th17 response via inhibiting IRF4-mediated glycolysis and ameliorates Sjog̈ren's syndrome.

Fan Xiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.